S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00

Intec Pharma Short Interest Ratio and Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
50-Day Range
52-Week Range
988,300 shs
Average Volume
543,436 shs
Market Capitalization
$8.65 million
P/E Ratio
Dividend Yield

Intec Pharma (NASDAQ:NTEC) Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
$2.54 million
Short Interest Ratio / Days to Cover
Last Record Date
July, 15 2021
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Intec Pharma ?

Sign up to receive the latest short interest report for Intec Pharma and its competitors with MarketBeat's FREE newsletter.

Intec Pharma (NASDAQ:NTEC) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/2021755,300 shares $2.54 million +42.8%16.1%0.5 $3.36
6/30/2021529,000 shares $1.84 million +92.5%11.3%0.4 $3.47
6/15/2021274,800 shares $1.07 million -39.8%5.9%0.2 $3.90
5/28/2021456,200 shares $1.72 million -8.3%9.7%0.5 $3.77
5/14/2021497,500 shares $1.72 million +39.8%10.6%0.5 $3.46
4/30/2021355,900 shares $1.47 million -31.9%8.1%0.3 $4.12
4/15/2021522,900 shares $2.12 million -13.7%12.0%0.7 $4.06
3/31/2021606,000 shares $2.53 million +5.9%13.9%0.6 $4.18
3/15/2021572,500 shares $2.63 million +5.0%14.1%0.6 $4.59
2/26/2021545,500 shares $2.62 million +5.5%15.3%0.5 $4.80
2/12/2021517,100 shares $3.44 million +1.2%14.5%0.4 $6.66
1/29/2021511,100 shares $2.18 million +4.2%14.4%0.5 $4.27
1/15/2021490,600 shares $2.13 million +283.9%13.6%0.5 $4.34
12/31/2020127,800 shares $469,026.00 -61.3%3.6%0.1 $3.67
12/15/2020330,400 shares $1.37 million +191.6%9.2%0.4 $4.14
11/30/2020113,300 shares $368,225.00 -18.4%3.2%0.2 $3.25
11/15/2020138,800 shares $466,368.00 +14.4%3.9%0.7 $3.36
10/30/2020121,300 shares $18,655.94 -96.2%3.4%0.5 $0.15
10/15/20203,200,000 shares $16.26 million -1.5%N/A0.7 $5.08
9/30/20203,250,000 shares $16.35 million +0.3%N/A0.4 $5.03
9/15/20203,240,000 shares $18.67 million +8.0%N/A0.5 $5.76
8/31/20203,000,000 shares $18.48 million -27.2%N/A0.4 $6.16
8/14/20204,120,000 shares $30.49 million -16.4%N/A0.4 $7.40
7/31/20204,930,000 shares $41.28 million +178.5%N/A0.5 $8.37
7/15/20201,770,000 shares $10.75 million -23.4%N/A0.2 $6.07

Intec Pharma (NASDAQ:NTEC) Short Interest Frequently Asked Questions

What is Intec Pharma's current short interest?

Short interest is the volume of Intec Pharma shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 755,300 shares of NTEC short. 16.10% of Intec Pharma's shares are currently sold short. Learn More on Intec Pharma's current short interest.

What is a good short interest percentage for Intec Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.10% of Intec Pharma's floating shares are currently sold short.

Is Intec Pharma's short interest increasing or decreasing?

Intec Pharma saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 755,300 shares, an increase of 42.8% from the previous total of 529,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Intec Pharma's float size?

Intec Pharma currently has issued a total of 898,000 shares. Some of Intec Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Intec Pharma currently has a public float of 4,690,000 shares.

How does Intec Pharma's short interest compare to its competitors?

16.10% of Intec Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Intec Pharma: Bio-Path Holdings, Inc. (2.08%), Bellerophon Therapeutics, Inc. (1.08%), Qualigen Therapeutics, Inc. (6.78%), Acer Therapeutics Inc. (0.37%), Integrated BioPharma, Inc. (0.00%), Can-Fite BioPharma Ltd. (0.00%), Predictive Technology Group, Inc. (0.00%), Benitec Biopharma Inc. (5.01%), Alimera Sciences, Inc. (3.75%), and Histogen Inc. (0.98%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.55 billion), Square, Inc. ($7.47 billion), S&P Global Inc. ($7.40 billion), Analog Devices, Inc. ($6.82 billion), Aon plc ($5.98 billion), Charter Communications, Inc. ($5.10 billion), Wayfair Inc. ($4.38 billion), AMC Entertainment Holdings, Inc. ($2.87 billion), Teladoc Health, Inc. ($2.55 billion), and Nuance Communications, Inc. ($2.41 billion). View all of the most shorted stocks.

What does it mean to sell short Intec Pharma stock?

Short selling NTEC is an investing strategy that aims to generate trading profit from Intec Pharma as its price is falling. To short Intec Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Intec Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Intec Pharma?

A short squeeze for Intec Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NTEC, which in turn drives the price of the stock up even further.

How often is Intec Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NTEC, twice per month. The most recent reporting period available is July, 15 2021.

This page was last updated on 10/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.